Human Cardiovascular ELISA Kits
Human ANG (Angiogenin) CLIA Kit (HUES00006)
- SKU:
- HUES00006
- Product Type:
- ELISA Kit
- ELISA Type:
- CLIA Kit
- Size:
- 96 Assays
- Sensitivity:
- 18.75pg/mL
- Range:
- 31.25-2000pg/mL
- ELISA Type:
- Sandwich
- Synonyms:
- ALS9, HEL168, RNASE4, RNASE5
- Reactivity:
- Human
- Sample Type:
- Serum, plasma and other biological fluids
- Research Area:
- Cardiovascular
Description
Assay type: | Sandwich |
Format: | 96T |
Assay time: | 4.5h |
Reactivity: | Human |
Detection method: | Chemiluminescence |
Detection range: | 31.25-2000 pg/mL |
Sensitivity: | 18.75 pg/mL |
Sample volume: | 100µL |
Sample type: | Serum, plasma and other biological fluids |
Repeatability: | CV < 15% |
Specificity: | This kit recognizes Human ANG in samples. No significant cross-reactivity or interference between Human ANG and analogues was observed. |
This kit uses Sandwich-CLIA as the method. The micro CLIA plate provided in this kit has been pre-coated with an antibody specific to Human ANG. Standards or samples are added to the appropriate micro CLIA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human ANG and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well successively and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human ANG, biotinylated detection antibody and Avidin-HRP conjugate will appear fluorescence. The Relative light unit (RLU) value is measured spectrophotometrically by the Chemiluminescence immunoassay analyzer. The RLU value is positively associated with the concentration of Human ANG. The concentration of Human ANG in the samples can be calculated by comparing the RLU of the samples to the standard curve.
UniProt Protein Function: | ANG: May function as a tRNA-specific ribonuclease that abolishes protein synthesis by specifically hydrolyzing cellular tRNAs. Binds to actin on the surface of endothelial cells; once bound, angiogenin is endocytosed and translocated to the nucleus. Angiogenin induces vascularization of normal and malignant tissues. Angiogenic activity is regulated by interaction with RNH1 in vivo. Defects in ANG are the cause of susceptibility to amyotrophic lateral sclerosis type 9 (ALS9). ALS is a degenerative disorder of motor neurons in the cortex, brain stem and spinal cord. ALS is characterized by muscular weakness and atrophy. Belongs to the pancreatic ribonuclease family. |
UniProt Protein Details: | Protein type:RNA-binding; Secreted, signal peptide; Ribonuclease; EC 3. 1. 27. -; Secreted; Motility/polarity/chemotaxis; Nucleolus; Extracellular matrix; Cell cycle regulation Chromosomal Location of Human Ortholog: 14q11. 1-q11. 2 Cellular Component: angiogenin-PRI complex; basal lamina; cell soma; cytoplasmic membrane-bound vesicle; extracellular region; extracellular space; growth cone; nucleolus; nucleus Molecular Function:actin binding; copper ion binding; DNA binding; endonuclease activity; heparin binding; peptide binding; protein binding; protein homodimerization activity; receptor binding; ribonuclease activity; rRNA binding Biological Process: actin filament polymerization; activation of phospholipase A2; activation of protein kinase B; angiogenesis; antibacterial humoral response; antifungal humoral response; cell communication; cell migration; defense response to Gram-positive bacterium; diacylglycerol biosynthetic process; homeostatic process; innate immune response; intercellular junction assembly and maintenance; negative regulation of smooth muscle cell proliferation; negative regulation of translation; oocyte maturation; ovarian follicle development; phospholipase C activation; placenta development; positive regulation of endothelial cell proliferation; positive regulation of phosphorylation; positive regulation of protein secretion; response to hormone stimulus; response to hypoxia; response to yeast; rRNA transcription Disease: Amyotrophic Lateral Sclerosis 9 |
NCBI Summary: | The protein encoded by this gene is an exceedingly potent mediator of new blood vessel formation. It hydrolyzes cellular tRNAs resulting in decreased protein synthesis and is similar to pancreatic ribonuclease. In addition, the mature peptide has antimicrobial activity against some bacteria and fungi, including S. pneumoniae and C. albicans. Alternative splicing results in two transcript variants encoding the same protein. This gene and the gene that encodes ribonuclease, RNase A family, 4 share promoters and 5' exons. Each gene splices to a unique downstream exon that contains its complete coding region. [provided by RefSeq, Aug 2014] |
UniProt Code: | P03950 |
NCBI GenInfo Identifier: | 113873 |
NCBI Gene ID: | 283 |
NCBI Accession: | P03950. 1 |
UniProt Secondary Accession: | P03950,Q05CV1, Q53X86, Q6P5T2, Q8WXE7, |
UniProt Related Accession: | P03950 |
Molecular Weight: | 16,550 Da |
NCBI Full Name: | Angiogenin |
NCBI Synonym Full Names: | angiogenin, ribonuclease, RNase A family, 5 |
NCBI Official Symbol: | ANG |
NCBI Official Synonym Symbols: | ALS9; RAA1; HEL168; RNASE4; RNASE5 |
NCBI Protein Information: | angiogenin |
UniProt Protein Name: | Angiogenin |
UniProt Synonym Protein Names: | Ribonuclease 5; RNase 5 |
Protein Family: | Angiogenin |
UniProt Gene Name: | ANG |
UniProt Entry Name: | ANGI_HUMAN |
As the RLU values of the standard curve may vary according to the conditions of the actual assay performance (e. g. operator, pipetting technique, washing technique or temperature effects), the operator should establish a standard curve for each test. Typical standard curve and data is provided below for reference only.
Concentration (pg/mL) | RLU | Average | Corrected |
2000 | 51297 60145 | 55721 | 55693 |
1000 | 21828 26120 | 23974 | 23946 |
500 | 11233 10831 | 11032 | 11004 |
250 | 5119 5469 | 5294 | 5266 |
125 | 2689 2527 | 2608 | 2580 |
62.5 | 1314 1308 | 1311 | 1283 |
31.25 | 634 714 | 674 | 646 |
0 | 27 29 | 28 | -- |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Human ANG were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Human ANG were tested on 3 different plates, 20 replicates in each plate.
Intra-assay Precision | Inter-assay Precision | |||||
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 107.95 | 252.88 | 924.50 | 113.60 | 240.62 | 994.18 |
Standard deviation | 9.51 | 23.52 | 83.02 | 10.41 | 23.58 | 81.03 |
C V (%) | 8.81 | 9.30 | 8.98 | 9.16 | 9.80 | 8.15 |
Recovery
The recovery of Human ANG spiked at three different levels in samples throughout the range of the assay was evaluated in various matrices.
Sample Type | Range (%) | Average Recovery (%) |
Serum (n=5) | 96-111 | 103 |
EDTA plasma (n=5) | 87-100 | 94 |
Cell culture media (n=5) | 95-110 | 103 |
Linearity
Samples were spiked with high concentrations of Human ANG and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.
Serum (n=5) | EDTA plasma (n=5) | Cell culture media (n=5) | ||
1:2 | Range (%) | 94-108 | 98-110 | 98-111 |
Average (%) | 101 | 104 | 105 | |
1:4 | Range (%) | 103-115 | 100-114 | 87-100 |
Average (%) | 109 | 107 | 93 | |
1:8 | Range (%) | 95-109 | 101-120 | 96-114 |
Average (%) | 101 | 109 | 104 | |
1:16 | Range (%) | 88-102 | 93-108 | 89-103 |
Average (%) | 93 | 100 | 94 |
An unopened kit can be stored at 4°C for 1 month. If the kit is not used within 1 month, store the items separately according to the following conditions once the kit is received.
Item | Specifications | Storage |
Micro CLIA Plate(Dismountable) | 8 wells ×12 strips | -20°C, 6 months |
Reference Standard | 2 vials | |
Concentrated Biotinylated Detection Ab (100×) | 1 vial, 120 µL | |
Concentrated HRP Conjugate (100×) | 1 vial, 120 µL | -20°C(shading light), 6 months |
Reference Standard & Sample Diluent | 1 vial, 20 mL | 4°C, 6 months |
Biotinylated Detection Ab Diluent | 1 vial, 14 mL | |
HRP Conjugate Diluent | 1 vial, 14 mL | |
Concentrated Wash Buffer (25×) | 1 vial, 30 mL | |
Substrate Reagent A | 1 vial, 5 mL | 4°C (shading light) |
Substrate Reagent B | 1 vial, 5 mL | 4°C (shading light) |
Plate Sealer | 5 pieces | |
Product Description | 1 copy | |
Certificate of Analysis | 1 copy |
- Set standard, test sample and control (zero) wells on the pre-coated plate and record theirpositions. It is recommended to measure each standard and sample in duplicate. Note: addall solutions to the bottom of the plate wells while avoiding contact with the well walls. Ensuresolutions do not foam when adding to the wells.
- Aliquot 100µl of standard solutions into the standard wells.
- Add 100µl of Sample / Standard dilution buffer into the control (zero) well.
- Add 100µl of properly diluted sample (serum, plasma, tissue homogenates and otherbiological fluids. ) into test sample wells.
- Cover the plate with the sealer provided in the kit and incubate for 90 min at 37°C.
- Aspirate the liquid from each well, do not wash. Immediately add 100µL of BiotinylatedDetection Ab working solution to each well. Cover the plate with a plate seal and gently mix. Incubate for 1 hour at 37°C.
- Aspirate or decant the solution from the plate and add 350µL of wash buffer to each welland incubate for 1-2 minutes at room temperature. Aspirate the solution from each well andclap the plate on absorbent filter paper to dry. Repeat this process 3 times. Note: a microplatewasher can be used in this step and other wash steps.
- Add 100µL of HRP Conjugate working solution to each well. Cover with a plate seal andincubate for 30 min at 37°C.
- Aspirate or decant the solution from each well. Repeat the wash process for five times asconducted in step 7.
- Add 100µL of Substrate mixture solution to each well. Cover with a new plate seal andincubate for no more than 5 min at 37°C. Protect the plate from light.
- Determine the RLU value of each well immediately.